CClinicalTrials.gg
CompletedNCT03922178Updated Jan 18, 2020

Evaluation of Hemodynamic Changes of the Left Ventricle Following the Use of Extracorporeal Circulation

An interventional study of Pressure/Volume Combination Catheter and Transthoracic echocardiography in Coronary Surgery, sponsored by Pierre Wauthy. Completed at 1 site in Belgium. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-01-18.

Sponsored by Pierre Wauthy · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Nov 2018, registered Apr 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The interpretation of perioperative measures of cardiac function during cardiac surgery is complicated. In particular, the evaluation of the diastolic compliance of the left ventricle. In addition, they are subject to variations induced by post-charge changes caused by the anesthesia, extracorporeal circulation (ECC) and the surgical procedure itself.

Left ventricular failure is frequently measured by alteration of LV contractile properties, and very rarely by alteration of LV compliance. However, both contractility (systolic) and relaxation (diastolic) parameters are important for the left ventricle to perform its function adequately. Left ventricular failure after cardiac surgery with extracorporeal circulation and cardiac arrest under cardioplegia protection is an important and frequently reported complication. The investigator's objectives are to characterize the diastolic hemodynamic mechanisms of this left ventricular failure and to identify predictors of this failure in the postoperative period.

The quantification of the systolic and diastolic functions of the left ventricle by ventricular pressure-volume curves is the technique of reference today, because it allows to determine parameters that are independent of the pre- and post-load conditions. Previous studies using the conductance catheter for the purpose of estimating left ventricular function perioperatively are rare and report conflicting results. In addition, they were mainly intended to measure the systolic function of the left ventricle. Only one reported the diastolic relaxation parameters evaluated by a conductance catheter. This study showed immediately after withdrawal of the extracorporeal circulation a significant alteration of the diastolic relaxation of the left ventricle, but was not interested in its early (kinetic) evolution peroperatively.

The investigator's experience shows that, in the quarter-hour following the weaning of the extracorporeal circulation, a decrease in filling pressures of the left ventricle concomitant with an increase in cardiac output is objectified. These observations are consistent with a significant improvement in left ventricle compliance, but have never been reported.

The objectives of this study are:

  • To characterize the left ventricular diastolic failure after withdrawal of the extracorporeal circulation in coronary surgery.
  • To identify the kinetics of this early diastolic failure after withdrawal of the extracorporeal circulation.
02

Conditions studied

  • Coronary Surgery
03

In context

Lead sponsor

Pierre Wauthy is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient of the CHU Brugmann Hospital receiving elective coronary surgery.
  • Patient in sinusal rhythm before the operation and during the collection of hemodynamic data.
  • Patients with conserved left ventricular function (based on left ventricular ejection fraction assessed by preoperative echocardiography and superior to 50%)

Exclusion criteria

Exclusion Criteria:

  • Hypertrophic cardiomyopathy (diastolic septal thickness> 15 mm)
  • Heart failure with left ventricular ejection fraction \<50%
  • Presence of cardiac valvulopathy, concerning both right and left atrio-ventricular and ventriculo-arterial valves
  • Presence of valvular prosthesis
  • Congenital heart disease
  • Pregnancy
  • Participation to another clinical study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Elective coronary surgery

    The study will be conducted at the CHU Brugmann Hospital, with collaboration between cardiac surgery and anesthesiology wards. Subjects referred for elective coronary surgery will be prospectively included during the length of the study.

    Device: Pressure/Volume Combination Catheter · Device: Transthoracic echocardiography · Device: Transesophageal echocardiogram

Interventions

  • DevicePressure/Volume Combination Catheter

    Hemodynamic data routinely collected and data collected by means of the placement of a Pressure/Volume Combination Catheter (Pressure/Volume Combination Catheter,Leycom,The Netherlands) will be collected simultaneously. The catheter will be placed and held in place as long as the patient is in a position to be assisted by extracorporeal circulation. This means that the placement of the catheter will follow the heparinization of the patient and the placement of the cannulas necessary for the realization of extracorporal circulation. It will be removed from the left ventricular cavity before removal of extra-corporal cannulas.

  • DeviceTransthoracic echocardiography

    A complete transthoracic echocardiography will be performed the day before the surgical procedure, as per standard of care. It will establish the presence of the inclusion and exclusion criteria and evaluate the contractile function of the left ventricle. This will be done using a Philips IE33 echocardiograph (Koninklijke Philips Electronics N.V., Netherlands).

  • DeviceTransesophageal echocardiogram

    A transesophageal echocardiogram will be performed during the cardiac surgery, as per standard of care, using an Acuson Sequoia system (Siemens AG, Germany). It will facilitate the placement of the pressure/volume combination catheter and collect echographic data.

06

What researchers measure

Primary outcomes

  1. Tele-systolic pressure of the left ventricle

    Pressure within the left ventricle after the atrial contraction, at the beginning of the ventricular contraction.

    Time frame: Baseline (before extracorporeal circulation is switched on)

  2. Tele-systolic pressure of the left ventricle

    Pressure within the left ventricle after the atrial contraction, at the beginning of the ventricular contraction.

    Time frame: 1 minute after extracorporeal circulation is switched on

  3. Tele-systolic pressure of the left ventricle

    Pressure within the left ventricle after the atrial contraction, at the beginning of the ventricular contraction.

    Time frame: 1 minute after extracorporeal circulation is stopped

  4. Tele-systolic pressure of the left ventricle

    Pressure within the left ventricle after the atrial contraction, at the beginning of the ventricular contraction.

    Time frame: 10 minutes after extracorporeal circulation is stopped

  5. Tele-systolic pressure of the left ventricle

    Pressure within the left ventricle after the atrial contraction, at the beginning of the ventricular contraction.

    Time frame: 20 minutes after extracorporeal circulation is stopped

  6. Diastolic pressure of the left ventricle

    The pressure within the left ventricle following the completion of diastolic filling, just prior to systole.

    Time frame: Baseline (before extracorporeal circulation is switched on)

  7. Diastolic pressure of the left ventricle

    The pressure within the left ventricle following the completion of diastolic filling, just prior to systole.

    Time frame: 1 minute after extracorporeal circulation is switched on

  8. Diastolic pressure of the left ventricle

    The pressure within the left ventricle following the completion of diastolic filling, just prior to systole.

    Time frame: 1 minute after extracorporeal circulation is stopped

  9. Diastolic pressure of the left ventricle

    The pressure within the left ventricle following the completion of diastolic filling, just prior to systole.

    Time frame: 10 minutes after extracorporeal circulation is stopped

  10. Diastolic pressure of the left ventricle

    The pressure within the left ventricle following the completion of diastolic filling, just prior to systole.

    Time frame: 20 minutes after extracorporeal circulation is stopped

  11. Tele-systolic volume of the left ventricle

    At the end of systole, the ventricle contains a quantity of blood called 'telesystolic volume'.

    Time frame: Baseline

  12. Tele-systolic volume of the left ventricle

    At the end of systole, the ventricle contains a quantity of blood called 'telesystolic volume'.

    Time frame: 1 minute after extracorporeal circulation is switched on

  13. Tele-systolic volume of the left ventricle

    At the end of systole, the ventricle contains a quantity of blood called 'telesystolic volume'.

    Time frame: 1 minute after extracorporeal circulation is stopped

  14. Tele-systolic volume of the left ventricle

    At the end of systole, the ventricle contains a quantity of blood called 'telesystolic volume'.

    Time frame: 10 minutes after extracorporeal circulation is stopped

  15. Tele-systolic volume of the left ventricle

    At the end of systole, the ventricle contains a quantity of blood called 'telesystolic volume'.

    Time frame: 20 minutes after extracorporeal circulation is stopped

  16. Diastolic volume of the left ventricle

    At the end of diastole, the ventricle contains a quantity of blood called end-diastolic volume.

    Time frame: Baseline

  17. Diastolic volume of the left ventricle

    At the end of diastole, the ventricle contains a quantity of blood called end-diastolic volume.

    Time frame: 1 minute after extracorporeal circulation is switched on

  18. Diastolic volume of the left ventricle

    At the end of diastole, the ventricle contains a quantity of blood called end-diastolic volume.

    Time frame: 1 minute after extracorporeal circulation is stopped

  19. Diastolic volume of the left ventricle

    At the end of diastole, the ventricle contains a quantity of blood called end-diastolic volume.

    Time frame: 10 minutes after extracorporeal circulation is stopped

  20. Diastolic volume of the left ventricle

    At the end of diastole, the ventricle contains a quantity of blood called end-diastolic volume.

    Time frame: 20 minutes after extracorporeal circulation is stopped

  21. Ejection volume of the left ventricle

    The ejection volume is the difference between systolic and diastolic volume. It represents the amount of blood ejected at each contraction by the ventricle.

    Time frame: Baseline

  22. Ejection volume of the left ventricle

    The ejection volume is the difference between systolic and diastolic volume. It represents the amount of blood ejected at each contraction by the ventricle.

    Time frame: 1 minute after extracorporeal circulation is switched on

  23. Ejection volume of the left ventricle

    The ejection volume is the difference between systolic and diastolic volume. It represents the amount of blood ejected at each contraction by the ventricle.

    Time frame: 1 minute after extracorporeal circulation is stopped

  24. Ejection volume of the left ventricle

    The ejection volume is the difference between systolic and diastolic volume. It represents the amount of blood ejected at each contraction by the ventricle.

    Time frame: 10 minutes after extracorporeal circulation is stopped

  25. Ejection volume of the left ventricle

    The ejection volume is the difference between systolic and diastolic volume. It represents the amount of blood ejected at each contraction by the ventricle.

    Time frame: 20 minutes after extracorporeal circulation is stopped

  26. Contractility index of the left ventricle

    Computed by the following formula: (dP/dt max)/P

    Time frame: Baseline

  27. Contractility index of the left ventricle

    Computed by the following formula: (dP/dt max)/P

    Time frame: 1 minute after extracorporeal circulation is switched on

  28. Contractility index of the left ventricle

    Computed by the following formula: (dP/dt max)/P

    Time frame: 1 minute after extracorporeal circulation is stopped

  29. Contractility index of the left ventricle

    Computed by the following formula: (dP/dt max)/P

    Time frame: 10 minutes after extracorporeal circulation is stopped

  30. Contractility index of the left ventricle

    Computed by the following formula: (dP/dt max)/P

    Time frame: 20 minutes after extracorporeal circulation is stopped

07

Study locations

1 site
  • CHU Brugmann
    Brussels, 1020, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03922178
Lead sponsor
Pierre Wauthy
Responsible party
Pierre Wauthy (Medical Director of the CHU Brugmann Hospital, Brugmann University Hospital) — Sponsor-investigator
First posted
Apr 19, 2019
Start date
Nov 13, 2018
Primary completion
Jan 16, 2020
Completion
Jan 16, 2020
Last update
Jan 18, 2020

Study contacts

Charlotte Leclercq, MD
principal investigator · CHU Brugmann

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion